Approximately 97% of individuals with FOP carry the recurrent activating mutation (617G>A, R206H) in the ACVR1/ALK2 gene, causing the substitution of a conserved residue in the GS domain of the protein. The gene discussed is ACVR1; the disease is fibrodysplasia ossificans progressiva.